Enjoy complimentary customisation on priority with our Enterprise License!
The anticoccidial drugs market size is forecast to increase by USD 85.2 million at a CAGR of 4.5% between 2023 and 2028. The market is experiencing significant growth due to the increasing demand for feed additives in response to rising disease outbreaks in livestock. Advances in biotechnology are leading to the development of more effective and innovative anticoccidial drugs, providing opportunities for market expansion. However, stringent government regulations and growing concerns over antimicrobial resistance pose challenges to market growth. The market is expected to continue its upward trajectory, driven by the need for efficient and cost-effective solutions to prevent coccidiosis in livestock production. The use of alternative therapies, such as probiotics and prebiotics, is also gaining popularity as a means of reducing reliance on traditional anticoccidial drugs and mitigating the risk of resistance. Overall, the market is characterized by a dynamic and evolving landscape, driven by a combination of market trends, regulatory requirements, and technological innovations.
The market refers to the segment of the animal health industry that deals with the production and distribution of drugs used to prevent and treat coccidiosis in animals. Coccidiosis is a common intestinal disease caused by parasitic organisms of the genus Eimeria, affecting various animal livestock animals and companion animals. The market includes ionophores, antibiotics, sulphonamides, and chemical derivatives, which function as either coccidiostatic or coccidiocidal agents. Ionophores, such as monensin and lasalocid, are widely used in cattle and poultry production. Antibiotics, like sulphonamides, are also used in the treatment of coccidiosis in animals. Creative Diagnostics is one of the key players in the Anticoccidial Market, offering a range of diagnostic services for zootonic diseases.
In addition, the increasing meat-eating population and demand for poultry and cattle products have fueled the growth of the Anticoccidial Market. Veterinary hospitals, livestock farms, and pet owners are the primary consumers of these drugs. The market is also driven by the growing awareness of animal and veterinary health, as well as the availability of advanced anticoccidial drugs. The use of anticoccidial drugs is essential in preventing the spread of coccidiosis through soil, clothing, shovels, pails, and other means.
The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD billion" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
The ionophore anticoccidial segment is estimated to witness significant growth during the forecast period. The Anticoccidial Market encompasses ionophores, antibiotics such as sulphonamides, and chemical derivatives used to prevent and treat coccidiosis in animal livestock and companion animals. Coccidiostats inhibit the multiplication of parasitic organisms like Eimeria tenella and other Eimeria species, while coccidiocidals eliminate the parasites. These diseases, which cause diarrhea and dehydration, can significantly impact breeding and productivity in animals. Creative Diagnostics offers a range of antimicrobial anticoccidial drugs for veterinary healthcare. Zoonotic diseases, such as coccidiosis, can spread from animals to humans, making animal health a critical concern for the meat-eating population. Antibiotic-free meat and poultry products are increasingly popular, necessitating effective alternatives to antibiotics for livestock health management.
In addition, veterinary hospitals and pet owners prioritize animal health, driving demand for anticoccidial drugs. Coccidiosis can lead to intestinal disease and reduced animal performance. The parasitic organism spreads through oocysts in soil, water, and on clothing, equipment, and other surfaces. Preventative measures, such as proper biosecurity practices and regular veterinary check-ups, are essential in managing coccidiosis. Government involvement and regulations play a crucial role in the anticoccidial market, ensuring the safety and efficacy of animal drugs. The market's growth is influenced by increasing awareness of veterinary healthcare, the rising demand for livestock and poultry products, and the need to maintain animal health and productivity.
Get a glance at the market share of various segments Request Free Sample
The Ionophore anticoccidial segment accounted for USD 169.80 million in 2018 and showed a gradual increase during the forecast period.
North America is estimated to contribute 52% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
For more insights on the market share of various regions Request Free Sample
The market encompasses ionophores, antibiotics such as sulphonamides, and chemical derivatives used to prevent and treat coccidiosis in animal livestock and companion animals. Coccidiostatic and coccidiocidal drugs are essential in controlling parasitic diseases like coccidiosis, which is caused by Eimeria species, including E. Tenella. This intestinal disease leads to diarrhea and dehydration, affecting breeding and productivity in cattle, poultry, and other animals. Creative Diagnostics offers a range of antimicrobial anticoccidial drugs for veterinary healthcare. Zootonic diseases, including coccidiosis, pose a significant threat to the meat-eating population due to the potential presence of oocysts in cattle products and poultry products.
Therefore, livestock health management and veterinary health awareness are crucial for maintaining animal health and ensuring antibiotic-free meat production. Government involvement in animal health regulations and initiatives, such as promoting preventive measures and implementing stricter regulations on the use of antibiotics, further prioritizes the importance of anticoccidial drugs in the livestock industry. Parasitic organisms, like Eimeria species, spread through soil, clothing, shovels, and pails, making it essential to maintain proper biosecurity measures to prevent infection.
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Growing demand for feed additives owing to rising disease outbreaks in livestock is the key driver of the market. Anticoccidial drugs play a crucial role in preventing coccidiosis, a disease that affects various livestock populations, including poultry, cattle, swine, and pet animals. Coccidiosis is caused by the ingestion of sporulated oocysts and can lead to nutrient deficiencies, reduced growth rates, and even increased mortality, depending on the species. This disease poses a significant challenge to the livestock industry, disrupting meat production and trade, and negatively impacting the sales of animal feed additives. To mitigate these risks, livestock producers are increasingly turning to advanced anticoccidial drugs, both synthetic and herbal, to protect their animals from this infection. These drugs improve overall feed absorption and assimilation, leading to better animal health and productivity.
In addition, the growing awareness and acceptance of anticoccidial drugs among veterinarians and meat producers are expected to drive the global market for these drugs during the forecast period. The environmental contamination caused by coccidiosis outbreaks further prioritizes the importance of using anticoccidial drugs to prevent the spread of this disease and maintain the health and wellbeing of livestock populations.
Advances in biotechnology is the upcoming trend in the market. The market is witnessing significant growth due to the increasing population of livestock, including poultry, cattle, swine, and pet animals. The demand for animal protein food is surging, leading meat producers to prioritize the health of their livestock. Anticoccidial drugs play a crucial role in preventing coccidiosis, a parasitic disease caused by Eimeria species. Advanced anticoccidial drugs are being developed through genomic analysis of these parasites, enabling the identification of species-specific protein targets. This may lead to the launch of new anticoccidial drugs and feed additives, such as the recent introduction of two new veterinary products by Elanco Animal Health Inc.
In Sri Lanka. Novel drug discovery approaches, including high-throughput screening, structural biology, and elucidation of active compounds' mode of action, are driving the development of new anticoccidial drugs. Additionally, concerns over environmental contamination from the use of synthetic drugs have led to an increased interest in herbal medicines as alternatives. The veterinary population and the health of puppies and kittens are also significant factors driving the market's growth.
Stringent government regulations is a key challenge affecting the market growth. Anticoccidial drugs are essential in the livestock industry for the prevention and treatment of coccidiosis, a parasitic disease that affects various animal populations, including poultry, cattle, swine, and pet animals. These drugs come in different forms, such as advanced synthetic drugs like robenidine, decoquinate, halofuginone, nicarbazin, and diclazuril, and herbal medicines. Government regulations impose restrictions on the use of veterinary drugs or feed additives, including anticoccidials. In the European Union, anticoccidial drugs are licensed as zootechnical animal feed additives under regulation 1831/2003/EC for species where coccidiosis is systematic, while in other species, they are registered as veterinary medicines. In the US, the use of medically important antibiotics in feed was restricted in 2017, requiring Veterinary Feed Directives (VFD) that mandate veterinary oversight.
Furthermore, these regulations aim to ensure animal health and food safety while minimizing the risk of environmental contamination and antimicrobial resistance. Meat producers, including those specializing in puppies and kittens, also benefit from the use of anticoccidial drugs to maintain the health of their livestock and produce high-quality meat products.
The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Bayer AG - The company offers anticoccidial that includes Polyether antibiotics, Ionophores, Monovalent ionophores, and Monovalent glycosidic ionophores.
The market research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The Anticoccidial Market refers to the segment of the animal health industry that deals with the production and sale of anticoccidial drugs. These drugs are used to prevent and treat coccidiosis, a parasitic disease caused by Eimeria species, in animals such as cattle, poultry, and companion animals. Anticoccidial drugs can be categorized into ionophores, antibiotics, and chemical derivatives, with coccidiostatic and coccidiocidal being the two main types. Ionophores, such as monensin and lasalocid, are ionophore anticoccidials, while sulphonamides and antibiotic-free antimicrobial drugs are antibiotic anticoccidials. Coccidiosis is a common zootonic disease that affects various animal livestock animals and companion animals, leading to diarrhea, dehydration, and intestinal disease.
Furthermore, the disease is caused by the parasitic organism Eimeria, which is spread through oocysts in the soil, water, and on clothing, shovels, and pails. The Anticoccidial Market is driven by the increasing demand for animal health and veterinary healthcare, veterinary health awareness, and the growing meat-eating population's demand for cattle products and poultry products. Key players in the market include Creative Diagnostics, Animals, and various other animal drug manufacturers. Government involvement in livestock health management also plays a significant role in market growth.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
139 |
|
Base year |
2023 |
|
Historic period |
2018-2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 4.5% |
|
Market growth 2024-2028 |
USD 85.2 million |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
4.24 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
North America at 52% |
|
Key countries |
US, Germany, UK, China, and Japan |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
Bayer AG, Bioproperties Pty Ltd., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Cronus Pharma, Elanco Animal Health Inc., HIPRA S A, Huvepharma EOOD, Impextraco NV, Kemin Industries Inc., Merck and Co. Inc., Novartis AG, Phibro Animal Health Corp., Qilu Animal Health Products Co., Ltd., Vetoquinol SA, VH Group, Virbac SA, and Zoetis Inc. |
|
Market dynamics |
Parent market analysis, market growth inducers and obstacles, market forecast, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, market condition analysis for the forecast period |
|
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
Secondary sources
DATA ANALYSIS
Data Synthesis
Data Validation
REPORT WRITING
Qualitative
Quantitative
Get the report (PDF) sent to your email within minutes.
Complimentary full Excel data with your report purchase.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
